At IGeneX, it is our mission to continue this research and work closely with physicians and scientists to improve testing for tick-borne related diseases.
As we have learned more about B. burgdorferi, other Borrelia, and the co-infecting organisms throughout the years that cause Lyme disease, we have continued to increase our menu of tests for tick-borne related diseases. Click here to learn more about our testing criteria. We were the first group to identify Borrelia burgdorferi in ticks in California. We were also the first to identify Babesia microti in New York, Switzerland, and Australia, using our exclusive patented FISH technology. Now we are the first to introduce Relapsing Fever Western Blot testing. Click here to learn more about our research and development.
Relapsing Fever mimics symptoms of Lyme disease. This issue has become a challenge for physicians finding suspected Lyme patients negative on standard tests. We now know that there are two groups of Borrelia known to cause disease in humans, including B. burgdorferi sensu lato that causes Lyme disease and the Relapsing Fever Borrelia group that causes tick-borne Relapsing Fever. Through commitment and steadfastness, IGeneX is the only lab today that accurately differentiates between the two. Click here to learn more about our type of tests.
At IGeneX, we excel in research and development. We spend an industry leading excess of 15 to 20 percent of our net profits on research and development to continuously improve our diagnostic testing. We look for more and detect more without a corresponding loss in specificity, no matter when patients were exposed to the tick-borne pathogen.